Official UK procurement notice
Generic Medicines Transition Tender
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") (NHS & healthcare)
What is being bought7 lots · detail below
Published requirement descriptionThis Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into 7 individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 9 bids on the busiest of 7 lots · 13 suppliers appointed
- Framework period
- 1 yr from 1 May 2022
Lots and requirements (7)Procurement structure
7 lots · all with a published value · same evaluation weights on every lotLot #1NP35922b - Treprostinil Solution for Infusion & Beclometasone / Formoterol InhalerAwarded ScotlandPublished value£616,659
The Supply of Treprostinil Solution for Infusion to NHS Scotland in a range of presentations.
The authority has not awarded the Beclometasone / Formoterol Inhaler.
The authority has awarded each product line as a multi-supplier unranked framework agreement.
Start Date: 01.05.22
End Date: 30.04.23
Lot #2NP35922c - Pirfenidone TabletsAwarded ScotlandPublished value£2,625,807
Supply of Pirfenidone Tablets in a range of presentations.
The authority has awarded each line to a single Framework Participant within the single supplier Framework Agreement.
Start Date: 01.05.22
End Date: 30.04.23
Lot #3NP39722b - Sorafenib & Thalidomide TabletsAwarded UKPublished value£731,678
The Supply of Sorafenib & Thalidomide Tablets to NHS Scotland in a range of presentations.
The authority has awarded each product line as a multi-supplier unranked framework agreement.
Start Date: 01.05.22
End Date: 31.01.23
Lot #4NP39722c - Sunitinib TabletsAwarded ScotlandPublished value£763,820
Supply of Sunitinib Tablets in a range of presentations.
The authority has awarded each line to a single Framework Participant within this single supplier Framework Agreement.
Start Date: 01.05.22
End Date: 31.01.23
Lot #5NP39822b - Deferasirox dispersible tablets, Hyoscine butylbromide tablets, Sapropterin soluble tablets & Tolvaptan TabletsAwarded ScotlandPublished value£2,602,694
Supply of Deferasirox dispersible tablets, Sapropterin soluble tablets & Tolvaptan tablets in a range of presentations.
The authority will not be awarding Hyoscine butylbromide tablets.
The authority has awarded each line to a single Framework Participant within this single supplier Framework Agreement.
Start Date: 01.05.22
End Date: 31.07.23
Lot #6NP40922b - Oxycodone/Naloxone TabletsAwarded ScotlandPublished value£3,296
The Supply of Oxycodone/Naloxone Tablets to NHS Scotland in a range of presentations.
The authority has awarded each product line as a multi-supplier unranked framework agreement.
Start Date: 01.05.22
End Date: 31.01.24
Lot #7NP40922c - Analgesics, Anaesthetics & Musculoskeletal Generic MedicinesAwarded ScotlandPublished value£200,000
The supply of additional generic medicines used as Analgesics, Anaesthetics & to treat musculoskeletal conditions. This includes the supply of Co-Codamol, Ibuprofen & Paracetamol in a range of presentations.
The authority has awarded each line to a single Framework Participant within this single supplier Framework Agreement.
Start Date: 01.05.22
End Date: 31.01.24
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Logistics: 5%
- price: 95%
Published award criteria (2)
- Logistics: 5
- Price: 95
- Suitability
Economic operators may be excluded from this competition if they are in breach of any of the situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
Minimum: a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL or PLGB number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender should be included in the Qualification Envelope of the ITT under the Technical…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “Generic Medicines Transition Tender” is a framework: the contest is a place on its panel, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 9 Feb 2022, 10:45 GMT
- Last source update
- 20 May 2022, 08:42 BST
- Award evaluation window
- 10 Mar 2022 – …
- FTS notice number
2022/S 000-013534- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0314bbFind a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:
An economic operator that suffers, or is at risk of suffering, loss or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.
The bringing of court proceedings against the Authority after the Framework Agreement has be entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section 11.1.7 & each lot cover(s) the contract duration for each individual Framework Agreement being awarded as a result of this procurement. (SC Ref:693776)
How it was run
Official notice- Appointment period ends
- 11 Mar 2022, 12:00 GMT
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 10 Mar 2022, 12:00 GMT
Timeline
10 Mar 2022 → 20 May 2022 · 4 dates- Bids opened10 Mar 2022, 12:00 GMT
- Admission / appointment period endsperiod end, not a bid countdown11 Mar 2022, 12:00 GMT
- Contract starts1 May 2022, 00:00 BST
- Notice published20 May 2022, 08:42 BST
Notice history
2 events · 3 releases on Find a Tender · since 9 Feb 2022- Deadline moved to 11 Mar 2022, 12:00 GMT9 Feb 2022, 10:45 GMT+1 days · was 10 Mar 2022, 12:00 GMT
- Status changed to complete20 May 2022, 08:42 BST
Published amendments (1 · 1 deadline change)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | DeadlineTime limit · IV.2.2 | 10 Mar 2022 | 11 Mar 2022 | +1 d |
| — | Bid openingConditions for opening of tenders · IV.2.7 | 10 Mar 2022 | 11 Mar 2022 | +1 d |
System Issues
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast7 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
NP35922b - Treprostinil Solution for Infusion & Beclometasone / Formoterol Inhaler
- Signed
- 20 Apr 2022
- Value
- £24,986
- Period
- … – 30 Apr 2023
- Status
- active
NP35922c - Pirfenidone Tablets
- Signed
- 20 Apr 2022
- Value
- £236,982
- Period
- … – 30 Apr 2023
- Status
- active
NP39722b - Sorafenib & Thalidomide Tablets
- Signed
- 20 Apr 2022
- Value
- £479,623
- Period
- … – 31 Jan 2023
- Status
- active
NP39722c - Sunitinib Tablets
- Signed
- 20 Apr 2022
- Value
- £14,970
- Period
- … – 31 Jan 2023
- Status
- active
NP40922b - Oxycodone/Naloxone Tablets
- Signed
- 20 Apr 2022
- Value
- £5,853
- Period
- … – 31 Jan 2024
- Status
- active
NP40922c - Analgesics, Anaesthetics & Musculoskeletal Generic Medicines
- Signed
- 20 Apr 2022
- Value
- £153,119
- Period
- … – 31 Jan 2024
- Status
- active
NP39822b - Deferasirox dispersible tablets, Hyoscine butylbromide tablets, Sapropterin soluble tablets & Tolvaptan Tablets
- Signed
- 20 Apr 2022
- Value
- £882,986
- Period
- … – 31 Jul 2023
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 1 · NP35922b - Treprostinil Solution for Infusion & Beclometasone / Formoterol Inhaler | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 2 · NP35922c - Pirfenidone Tablets | 5bids · 5 electronic · 5 from abroad | 0 | — | — |
| 3 · NP39722b - Sorafenib & Thalidomide Tablets | 6bids · 6 electronic · 6 from abroad | 0 | — | — |
| 4 · NP39722c - Sunitinib Tablets | 8bids · 8 electronic · 8 from abroad | 0 | — | — |
| 5 · NP39822b - Deferasirox dispersible tablets, Hyoscine butylbromide tablets, Sapropterin soluble tablets & Tolvaptan Tablets | 9bids · 9 electronic · 9 from abroad | 0 | — | — |
| 6 · NP40922b - Oxycodone/Naloxone Tablets | 2bids · 2 electronic · 2 from abroad | 0 | — | — |
| 7 · NP40922c - Analgesics, Anaesthetics & Musculoskeletal Generic Medicines | 4bids · 4 electronic · 4 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Edinburgh Sheriff CourtReview body
Framework contractors & participating bidders
13 commercial parties on the notice- AOP Orphan LtdFramework contractor
- Accord-UK LtdFramework contractor
- Aguettant LtdFramework contractor
- B.Braun Medical LimitedFramework contractor
- Bayer PlcFramework contractor
- Bristol-Myers Squibb PharmaceuticalsFramework contractor
- Dr Reddy's Laboratories (UK) LtdFramework contractor
- Martindale PharmaFramework contractor
- Napp PharmaceuticalsFramework contractor
- Piramal CCFramework contractor
Show 3 more suppliers
- Sandoz LtdFramework contractor
- Teva UK LimitedFramework contractor
- Zentiva Pharma UK LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.